 WALTHAM, Mass., June 10, 2021 GLOBE NEWSWIRE -- Minerva Neurosciences, Inc. NASDAQ: NERV, a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system CNS disorders, today announced that it will participate in the virtual JMP Securities Life Sciences Conference on June 16, 2021 at 10:00 a.m. Eastern Time. 